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Abstract Urinary tract infection (UTI) is a predominant
condition in prostate cancer patients. Escherichia coli
ORN178 (EC-178) is the uropathogen that causes recurrent
infection by binding specifically to adhesins of prostate
cancer cells (DU-145 cells). Gold nanoparticles (GNPs)
have been used in biodiagnosis of pathogens. In this study,
we have investigated the binding time of EC-178 to DU-145
cells, the cytotoxicity and uptake of plain and mannose
functionalized and 20 and 200 nm GNPs (D-mannan (Mn)-
GNPs). We also investigated the protein corona of GNPs
when incubated with fetal bovine serum to study the protein
corona which decides the biological fate of the GNPs. It was
seen that EC-178 binds and is inside the DU-145 cells by 3 h
of incubation period. Plain 20 nm GNPs decrease the per-
centage of viable cells in 48 and 72 h in log and lag phase of
DU-145 cells. It was also observed that the Mn-GNPs were
taken up by the DU-145 cells significantly more than the
plain GNPs. Protein corona was observed when GNPs were
incubated with fetal bovine serum which was confirmed by
dynamic light scattering measurements and SDS-PAGE gel.
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1 Introduction
The estimated risk of prostate cancer is 21 % and the
lifetime risk of death is 2–5 %. Even though it can be
diagnosed early and therapy can be started immediately,
patients developing metastatic conditions die. Apart from
the potent issue of cancer, recurrent urinary tract infection
(UTI) is one of the most prevalent symptoms (Klein and
Thompson 2012). Escherichia coli ORN178 are the most
common cause of UTI in humans. Various urovirulence
factors of E. coli ORN178 have been identified such as
molecular biology of surface receptors of the urothelial cells
of the urinary tract, the adhesin specificity and primarily and
the type 1 fimbriae associated with the organism (Sokurenko
et al. 1997). Detection, diagnosis, and treatment of UTI play
an important role in prostate cancer. One of the novel tools
currently vastly studied are nanoparticles. Nanoparticles
continue to be used as carriers for localized drug diffusion
to treat and detect infections and diseases like cancer (Chen
et al. 2008). Owing to their nano size, it is easy for these
particles to diffuse into the cells and effect desired responses
in treatment of diseases. However, the size, type, and sur-
face charges of the particles play a vital role. Of the different
kind of nanoparticles, gold nanoparticles (GNPs) have been
extensively studied in this regard. It has been shown that E.
coli ORN178 binds specifically to D-mannose, which is an
integral part of the glycoproteins that are a part of the
adhesive domain on host cells (Sharon 2006). The fimbriae
of the uropathogenic E. coli ORN178 bind to the urolapkins
on the surface of urothelial cells of the human bladder. We
have demonstrated D-mannose functionalized 200 nm GNPs
bind specifically to E. coli ORN178 (Vedantam et al. 2012).
Continuing in the same direction in this study, we attempt to
see if GNPs can be used as specific biodiagnostic tool to
detect and treat UTI in prostate cancer cells (DU-145). This
study investigates the binding time of E. coli ORN178 and
E. coli ORN208 to DU-145 cells. It has been shown that E.
coli ORN178 binds specifically to D-mannose only and E.
coli ORN208 serves as a negative control as it has type 1 pili
that fail to bind to D-mannose. In order to study the cyto-
toxicity of plain and functionalized 20 and 200 nm GNPs to
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DU-145, growth curve of the prostate cancer cells was done.
Cytotoxicity tests in log and lag phase were performed to
study their biocompatibility in vitro. Cellular uptake of
GNPs was estimated and protein corona of GNPs was
studied (Table 1).
2 Materials and methods
The strains E. coli ORN178 and 208 were provided by Dr.
Chu-Cheng Lin, Department of Zoology, National Taiwan
Normal University and were transformed with plasmid
pGREEN by electroporation (Sambrook and Russell
2001). Two different GNPs: 20 and 200 nm were purchased
from Ted Pella Inc., USA. The concentration of 20 nm GNPs
was 7×1011particles/ml and 200 nm GNPs was 7×108
particles/ml. The sugar D-mannan (Mn) was purchased from
VWR (USA). The sugar was dissolved in 0.3 M sodium
phosphate buffer. Surface functionalization of GNPs with
the Mn was carried out by a modified multistep procedure
(Aslan et al. 2004; Vedantam et al. 2012). All chemicals
required for functionalizing GNPs were purchased from
VWR, USA.
Human prostate carcinoma cell line DU-145 was gra-
ciously given by Dr Arun Sreekumar, Baylor College of
Medicine, Houston, TX, USA. Dulbecco’s modified Eagle’s
medium (DMEM) was modified to contain Earles Balanced
Salt Solution, non-essential amino acids, 2 mM L-glutamine,
1 mM sodium pyruvate, and 1,500 mg/L sodium bicarbon-
ate. It was supplemented with fetal bovine serum to a final
concentration of 10 %, 100 UI/ml penicillin G, and
100 μg/ml streptomycin in a humidified incubator with
5 % at 37 °C. All the media components were purchased
from Promega, USA.
2.1 Binding of E. coli to DU-145 cells
An eight-well chamber slide was used to perform the
bacterial cell adhesion assay to DU-145 cells. A total of
0.5 ml of DU-145 cells (1.5×106cells/ml) was seeded in
each well. The chamber slide was incubated at 37 °C
overnight for attachment and fresh media was added.
Fresh cultures of E. coli ORN178 (EC-178) and E. coli
ORN208 (EC-208) were cultured overnight in Tryptic
Soy Broth with ampicillin (50 μg/ml). The cultures were
washed and resuspended in sterile PBS. A 100 μl (3×108
cells/ml) aliquot of EC-178 and 208 was added to two wells
each in the chamber slide. The slide was incubated for 1, 2,
and 3 h. At the three different time periods, wells were washed
with PBS and images were taken by a fluorescent scope (Zeiss
LSM-510).
2.2 DU-145 cell growth curve
Cells were plated 96-well microtiter plates at initial densities
of 1,000, 2,000, 4,000, and 8,000 cells per well. The cell
culture medium was changed every 3 days. Cell growth was
tested by the CellTiter 96® AQueous One Solution Cell
Proliferation Assay (MTS) purchased from Promega, USA.
It is a colorimetric method for determining the percentage of
viable cells that are proliferating. Briefly, theMTS tetrazolium
is bioreduced by the viable cells into a colored formazan
product which is stable and can be measured at an absorbance
of 490 nm. The amount of formazan produced is directly
proportional to the number of living cells in the well. MTS
assays were performed every day after seeding until day8. All
the experiments were carried out in triplicates.
2.3 Cytotoxicity of GNPs to DU-145 cells
The cytotoxicity of plain GNPs was tested by CellTiter 96®
AQueous One Solution Cell Proliferation Assay (MTS)
purchased from Promega, USA. Cytotoxicity was measured
in both the logarithmic and stationary phase of cell growth.
For cytotoxicity measurements in the logarithmic phase, each
cell line was incubated for 72 h in 96-well plate before adding
the GNPs. Fresh medium containing increasing three different
concentrations of the GNPs (10, 50, and 100 μl) was added to
each well and the cells were incubated for 6, 24, 48, and 72 h
time periods. The samewas done for testing cytotoxicity in the
stationary phase. MTS assay was performed and the percent-
age of cell viability was determined.
2.4 Cell uptake assay of plain and Mn-GNPs
DU-145 cells (10 ml) were seeded in a cell culture dish
containing 2×106 cells and cultured overnight. Once the
cells were 70 % confluent, they were treated with plain
and mannose functionalized 20 and 200 nm GNPs (50 μl).
After 3 h of incubation, the unbound GNPs in the cell
culture treatments were removed by washing the cells with
PBS buffer twice. The cells were trypsinized with Trypsin–
EDTA and centrifuged. After removal of the supernatant,
the cells were resuspended in PBS to a final volume of 5 ml.
At this stage, the total number of cells was quantified with a
hemocytometer. Five milliliters of 50 % nitric acid (HNO3)
was added to each sample to lyse the cells. Inductively
Table 1 Hydrodynamic size distribution of GNPs
Sample Size (nm) Zeta potential (mV)
20 nm GNP 24±2.1 −54.4
Protein coated 20 nm GNP 66.61±2.3 −18.2
200 nm GNP 213.5±2.9 −49.3
Protein coated 200 nm GNP 261.9±5.3 −13.3
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coupled plasma mass spectrometry was performed to mea-
sure the gold mass in the various samples. The total number
of GNPs was calculated via the gold mass. The total number
of GNPs in the solution was divided by the number of cells
to determine the number of GNPs taken up by the cells
(Connor et al. 2005).
2.5 Cytotoxicity of functionalized GNPs to DU-145 cells
and E. coli ORN178
The cytotoxicity of functionalized Mn-GNP of 200 nm par-
ticles was carried out by adding 200 μl of DU-145 cells
(1.5×106 cell per well) into a 96-well plate. After incubation
at 37 °C for 24 h, the cells were treated with 200 nm Mn-
GNPs, 200 nm Mn-GNPs with bacteria EC-178 and 208. A
total of volume 50 μl of 200 nm Mn-GNPs was added. A
preincubated mix, 1 ml of the 200 nm Mn-GNPs and 1 ml of
the microorganisms was incubated at 37 °C with shaking for
1 h. The solution was centrifuged and washed with sterile
PBS and resuspended in sterile PBS before adding to the 96-
well plates. Different plates were set up for 6-, 12-, 24-, 48-,
and 72-h time periods. The MTS assay was performed and
the cell viability was determined.
2.6 Protein corona of commercial 20 and 200 nm GNPs
We wanted to study the protein adsorption of the com-
mercial 20 and 200 nm GNPs to fetal bovine serum
(FBS) in DU-145 cell culture media and DMEM. The
20 and 200 nm GNPs were incubated with DMEM and
cell culture medium for 1 h at 37 °C. The 20 nm GNPs
samples were spinned down at 10,000×g for 10 min.
The soups from FBS and DMEM samples were saved.
The pellet containing the particles was washed thrice
with nanopure water at 10,000×g. The particles were
finally resuspended in nanopure water. The 200 nm
GNPs were spinned down at 2,655×g for 10 min. The
soups from FBS and DMEM samples were saved. The
pellet containing the particles was washed thrice with
nanopure water at 2,655×g. The particles were finally
resuspended in nanopure water. Samples of pure
nanoparticles of both 20 and 200 nm GNPs, DMEM
and cell culture medium were also included to compare
the binding of the FBS proteins to the nanoparticle
surface. SDS-PAGE was performed for all the samples
using a 4–20 % gel (Biorad, USA). The gel was
stained by Coomassie blue stain. A Smart Protein stan-
dard (Genscript, USA) was used to identify and analyze
the presence of FBS bound to the samples. The gel
bands were cut up and image taken accordingly. The
hydrodynamic size of the plain GNPs and protein-
bound GNP samples were measured using dynamic
light scattering (DLS) using Malvern Zetasizer.
2.7 Statistical analysis
All experiments were carried out in triplicates with results
expressed as mean±standard error. Statistically significant
differences were calculated using the two-tailed unpaired t
test or one-way analysis of variance with p values of ≤0.05,
<0.01, and <0.001 considered significant using Prism 5.0
(GraphPad Software, CA, USA).
3 Results
3.1 Binding of E. coli to DU-145 cells
The binding of EC-178 and 208 to DU-145 was studied for
1, 2, and 3 h. Phase contrast images were taken as shown in
Fig. 1. It was seen that the EC-208 cells did not bind to DU-
145 cells at all during all the three time periods which is
expected as it serves as a negative control (Fig. 1b). On the
contrary, the EC-178 cells tend to bind to the cell wall of the
DU-145 cells at 2-h time period (Fig. 1d). After the 3-h time
period, they appear to be inside the DU-145 cell line
(Fig. 1e). Due to the wash step after time periods, it is seen
that only few cells manage to bind and enter the cell line
between 2 and 3 h.
3.2 DU-145 cell growth curve
In order to quantify the toxicity of the 20 and 200 nm
GNPs in DU-145 cells, a growth curve was carried out.
Since cells that actively grow and divide during the
logarithmic growth should be more vulnerable to toxic
metallic particles than cells that are nearing or at the
stationary phase of cell culture. Thus, the growth curve
was determined to estimate the logarithmic and station-
ary growth phases in relation to the number of cells
seeded into each well of a 96-well culture plate (Fig. 2).
It was observed that the cells reach the logarithmic
phase by 3–4 days of incubation. By the eighth day,
the stationary phase kicks in.
3.3 Cytotoxicity of GNPs to DU-145 cells
The cytotoxicity of 20 and 200 nm GNPs at the different
time points in log phase is shown in Fig. 3. It is seen that the
20 nm GNPs seem to have a significant effect on the DU-
145 cells only after 48 and 72 h of incubation period in all
the three concentrations. Not much difference in viability is
observed by 200 nm GNPs in the log phase when compared
to 20 nm GNPs. It is seen that the size did not cause much
decrease or increase in cell viability. In case of the stationary
phase (Fig. 4), the cytotoxicity of 20 and 200 nm GNPs is
significant as they show 24–31 % reduction in cell viability
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at midrange of concentration (50 μl) compared to other low
and high concentrations. Hence, it was observed that the
midrange of 50 μl volume of GNPs significantly affected
the percent cell viability in both log and stationary phase.
3.4 Cell uptake assay of plain and Mn-GNPs
After exposure to 20 and 200 nm plain and Mn-GNPs
to DU-145 cells for 3 h, the average number of GNPs
per cell associated with each DU-145 cell was estimated
as shown in Fig. 5. The number of GNPs per cell in
DU-145 cells was 3.4×104 for plain 20 nm GNP where
as it was 1.7×104 for 200 nm plain GNPs. In contrast,
exposure to 20 nm Mn-GNPs results in as much twice
the increase of nanoparticle uptake compared to the
plain 20 nm plain GNPs. There was a significant in-
crease in the uptake of the 200 nm Mn-GNPs, more
than double the number of GNPs when compared to the
plain 200 nm GNPs. There does not seem to be a
significant difference between uptake levels of Mn-
GNPs (both 20 and 200 nm).
Fig. 1 a DU-145 cells with
EC-178 at 0 min, b DU-145
cells with EC-208, c DU-145
cells with EC-178 at 1 h, d
bright field flourescent image of
DU-145 cells with EC-178 at
2 h, e DU-145 cells with EC-
178 at 3 h, f control DU-145
cells. ×200 magnification. Scale
bar 10 μm
Fig. 2 Cell growth curve of DU-145 using different cell-plating
numbers
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3.5 Cytotoxicity and competitive binding of functionalized
GNPs to DU-145 cells and EC-178
Figure 6 shows the cytotoxicity of functionalized GNPs to
the DU-145 cells at 1–6 h time points. A midrange concen-
tration of 200 nm Mn-GNPs (50 μl) was used in this assay.
After various binding assays, it was seen that 50 μl is the
minimum concentration 200 nm Mn-GNPs required to ef-
fect binding. It is seen that mannose functionalized 200 nm
GNPs when bound to EC-178 relatively show the same
percent viability when compared to the control DU-145
cells. On the other hand, the EC-178 bacterial cells bring
about cell death in about 6 h. When the 200 nm Mn-GNPs
and EC178 are added together at once to the DU-145 cells,
64 % viability of the cell line is observed. But, when the
200 nm Mn-GNPs are premixed with EC-178 and then
added to the DU-145 cell 73 % viability is observed. This
shows that when they are premixed the functionalized GNPs
bind to EC-178 and prevent the binding of the latter to DU-
145, thereby increasing the cell viability. Even though the
increase is not significant, it shows that there could be
competitive binding between EC-178 and 200 nm Mn-
GNPs to bind to DU-145 cells. This also suggests that the
Mn-GNPs could competitively bind to the cell surface that
has mannose residues and there by block the attachment of
bacteria to those mannose residues on the DU-145 cell
surface receptors (Miura et al. 2001).
3.6 Protein corona of GNPs
The hydrodynamic sizes of the plain and protein coated
GNPs did increase when incubated with FBS (Fig. 7). The
DLS measurements indicate that the protein in FBS did
adsorb and hence the increase in diameter. The 20 nm GNPs
were found to be of 66.61±2.3 nm size and the 200 nm
showed increase in size were of 261.9±5.3 nm. This
Fig. 3 Cell cytotoxicity profiles of DU-145 cells in log phase. a Cell
viability of DU-145 in log phase when treated with plain 20 nm GNPs
and b cell viability of DU-145 in log phase when treated with 200 nm
GNPs. *p<0.05, ***p<0.001
Fig. 4 Cell cytotoxicity profiles of DU-145 cells in lag phase. a Cell
viability of DU-145 in lag phase when treated with plain 20 nm GNPs
and b cell viability of DU-145 in lag phase when treated with 200 nm
GNPs. **p<0.01, ***p<0.001
Fig. 5 DU-145 cell uptake of plain GNPs (P-GNP) and mannose
functionalized GNPs (Mn-GNPs). ***p<0.001
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confirms the presence of protein corona which remained
coated even after multiple washes. The zeta values do show
good stable protein coated 20 and 200 nm GNPs (Table 1).
The SDS-PAGE gel was done to confirm the same (Fig. 8).
The 20 and 200 nm GNPs (arrow marks) do confirm the
presence of protein corona with a clear thick band. The sam-
ples incubated with plain DMEM did not show any bands at
all. Hence, it is clear that there was protein bound to the GNPs.
4 Discussion
Application of chemotherapy with GNPs is a new treatment
approach in cancer therapy (Lehmann et al. 2008). There
has been extensive research done and many underlying
reasons have been identified for the invasiveness of prostate
cancer. Cell–cell adhesion molecules that are involved in
cell aggregation are calcium-dependent moieties known as
cadherins. When there is a dysfunction in the cadherin
pathway cancer tumor tends to become invasive. E-
cadherin is a marker of carcinogenesis in prostate cancer.
The cadherin family proteins have mannose residues on
their cell surface receptors (Paul et al. 1997). These man-
nose residues also are detected by the uropathogenic bacte-
ria E. coli. Keeping this in mind, the 200 nm GNPs were
only functionalized with mannose to test adhesion and
cytotoxicity. The bigger size GNPs were used to
functionalize with mannose than 20 nm GNPs because
due to their increased size. If they bind to the DU-145
cells and competitively block the mannose residues from
becoming available for uropathogenic bacteria. Also, if
the Mn-GNPs do bind to the prostate cancer cells, then
the uropathogenic bacteria can detect, and chemotacti-
cally and specifically adhere to the mannose bound to
GNPs. Once, many bacteria are bound to the GNPs, due
to their bigger size and the peristaltic flow near the
tissue, the GNP-bacterial complex could be dislodged
and can be detached from the prostate cancer cells. If
this happens, then the severity of the UTI can also be
diagnosed, treated, and prevented. As it was seen that
the DU-145 cells are actively reproducing in log phase
by 48 h of incubation, the cytotoxicity profiles indicated
that there is no significant toxicity at all in 6- and 24-h
incubated periods. Hence, Mn-GNPs can be safely used
for detection or treatment of prostate cancer or UTI.
The viability profiles of DU-145 cells also indicate that
the plain and Mn-GNPs do significantly decrease the
viable cells by 48–72 h of incubation. Hence, if Mn-
GNPs are used as a drug carrier can bring about
Fig. 7 Hydrodynamic size distribution of a protein-coated 20 nm GNP
and b protein-coated 200 nm GNP
Fig. 8 Coomassie-stained SDS-PAGE gel lanes for protein coated 20
and 200 nm GNPs. FBS is a combination of various proteins. The lanes
“20 nm serum and 200 nm serum” show a band for protein bound to
the GNPs suggesting the presence of protein corona. The samples
incubated with plain DMEM did not show any protein bands (data
not shown)
Fig. 6 DU-145 cell growth pattern with different treatments at 6-, 12-,
24-, 48-, and 72-h time points
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synergistic killing of the prostate cancer and such a
treatment is could be localized treatment and site direct-
ed when introduced locally.
Compared to the 20 nm plain and Mn-GNPs were taken
up by the DU-145 cells, more than the 200 nm plain and
Mn-GNPs. It has been documented that 15 nm glucose
functionalized GNPs have been taken up more than the plain
or chemically functionalized GNPs (Zhang et al. 2008).
They have also demonstrated there is enhanced radiation
sensitivity in prostate cancer by GNPs. Hence, if GNPs are
functionalized with mannose sugar, they can be used as a
vehicle to treat UTI. Gold nanoparticles are heavy metals
with increased f factor that enhance radiosensitivity have been
studied in mice (Hainfeld et al. 2004; Wilson et al. 2009).
They attributed the sensitivity to the high-Z radio-
enhancement by GNPs. Since the uptake studies of GNPs in
this study indicate that 20 nm Mn-GNPs are taken up more
than 200 nmMn-GNPs, they could be used for killing the DU-
145 cells in promising clinical applications if used as drug
carrier. The 200 nmMn-GNPs can be used for antiadhesion of
uropathogenic bacteria in prostate cancer cells. This approach
can be used for future treatment of UTI cases as there is an
increase in antibiotic resistance of microorganisms.
For this, the uptake of the GNPs and their interaction
with cellular proteins is essential. Hence, the protein
adsorption of FBS on the 20 and 200 nm GNPs was
studied. The DLS measurements and the SDS-PAGE gel
indicate a strong band confirming the presence of the
protein corona around the GNPs. It is crucial to know
how the nanoparticles behave in blood plasma and in
vivo in general. Hence, there have been many studies where
the GNPs have been studied in depth to understand the protein–
nanoparticle complexes in vitro to make the nanoparticles more
robust and practical for various clinical applications. The chem-
ical functionalization, size of the nanoparticle, type of proteins,
and surface charges do decide the biological fate of the nano-
particle when administered for therapeutic purposes (Pan et al.
2007; Nativo et al. 2008; Arnida et al. 2010). This protein
corona is important as it decides the particle’s longevity in the
blood stream which is very important for therapeutic efficacy. It
has been shown that 30 and 50 nm citrate-stabilized gold
colloids were bound to 69 different proteins in plasma
(Dobrovolskaia et al. 2009). It has been also demonstrated that
the kinetic and equilibrium binding properties depend on pro-
tein identity as well as particle surface characteristics and size
(Cedervall et al. 2007). In order to understand the transport
pathways utilized by nanoparticles, it is necessary to know how
long they lived in the living system, which will determine its
biological fate (Lundqvist et al. 2011). Researches have dem-
onstrated that 15 nm GNPs form proteins/NP complexes in
RPMI are more abundantly internalized in cells as compared
to DMEM, overall exerting higher cytotoxic effects in HeLa
cells (Maiorano et al. 2010). It is important to understand what
happens to the fate of the nanoparticles once they have been
utilized for biological applications.
5 Conclusion
It has been shown previously in our previous investigation
that GNPs when functionalized with D-mannose bind spe-
cifically to only EC-178 (Vedantam et al. 2012). Based on
this fact, our investigation attempted to carry out cytotoxic-
ity assays with plain and Mn-GNPs it is seen that 20 and
200 nm GNPs bring out significant decrease in cell viability
by 48–72 h only both in log as well as lag phase of DU-145
cells. Also, it has been shown that there might be a compet-
itive binding between Mn-functionalized and GNPs when
present together with DU-145 cells. The plain 20 nm GNPs
were more inside the cell when compared to the plain
200 nm GNPs. The Mn-GNPs of 20 nm size were also taken
up more compared to the 200 nm Mn-GNPs. It was also
demonstrated that both 20 and 200 nm GNPs do bind to
protein and form a stable protein corona. Since it has been
shown that GNPs of different sizes between 20 and 100 nm
have shown to alter signalling pathways in cells and mediate
biological processes (Jiang et al. 2008), based on which they
can be used for targeted drug delivery as well as for detec-
tion purposes. Lastly, the binding of EC-178 shows that
competitive binding to Mn-GNP can be done to avoid
binding of the bacteria to the DU-145 cells and hence, this
mechanism can be further developed to prevent/detect re-
current UTI in prostate cancer cells.
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